White Paper

The Sunshine Act: What Sponsors And CROs Should Know

Source: Endign

Last week was the annual Partnerships in Clinical Trials conference in Orlando. As usual, Endign had a booth and I was in it most of the conference. There were many take aways for me this year but the biggest for me was the lack of concentration and information on HCP Aggregate Spend (the Sunshine Act and PPSA are other terms used to describe it). It's as if the whole industry is ignoring the issue hoping it will simply disappear. I heard everything from "that doesn't apply to us" to "I'm sure we'll care when we get fined".

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader